Cyient Share Buyback: Last Date to Buy Shares for ₹720 Crore Offer

Engineering and technology services major Cyient is set to execute a significant share buyback worth ₹720 crore, offering investors a premium exit. Shareholders looking to participate in this corporate action must ensure their holdings are credited before the upcoming record date.

Critical Deadlines for Investors

For investors aiming to benefit from the buyback, timing is everything. Cyient has fixed Wednesday, June 17, as the official record date. Under SEBI’s T+1 settlement norms, shares purchased must be credited to the investor's demat account by the record date to establish eligibility.

Consequently, Tuesday, June 16, serves as the final deadline to purchase Cyient shares. Investors who buy the stock on or before this Tuesday will be eligible to tender their shares for the buyback process. Only those appearing in the company's records on Wednesday will be permitted to participate.

Terms and Details of the ₹720 Crore Buyback

This marks the first time since 2019 that Cyient has initiated a share buyback. The company has announced plans to repurchase up to 64 lakh shares at a fixed price of ₹1,125 per share. This offer price represents a substantial premium of more than 25% over the stock's previous closing price, making it an attractive proposition for long-term holders.

The company has already received shareholder approval for this move. While the buyback aims to utilize surplus cash and enhance shareholder value, the specific entitlement ratio and further procedural details are expected to be announced in due course.

Market Performance and Brokerage Outlook

Despite the attractive buyback premium, Cyient’s stock has faced significant pressure in recent periods. On Tuesday morning, shares traded at approximately ₹886, down over 1%. While the stock has shown some resilience with a 2% gain over the last week, it has struggled significantly in the broader timeframe, falling over 20% in 2024 and down 33% over the past year.

Penganalisis pasaran kekal berhati-hati. Emkay Global telah mengekalkan saranan ‘Reduce’ terhadap saham tersebut. Walaupun firma broker tersebut meningkatkan harga sasaran daripada ₹850 kepada ₹900, ini masih menunjukkan kenaikan yang kecil daripada tahap semasa. Pendirian berhati-hati ini berpunca daripada pertumbuhan yang perlahan dalam FY26 yang disebabkan oleh rintangan makroekonomi dan peningkatan hari pusing ganti inventori DLM akibat cabaran rantaian bekalan. Walau bagaimanapun, pihak pengurusan kekal optimis untuk memberikan pertumbuhan yang lebih kukuh dan lebih menguntungkan dalam FY27.

Ringkasan Utama